Last reviewed · How we verify
NCT04010344: ADHINCRA
Addressing Hypertension Care in Africa
NA trial testing Enhanced Usual Care Group in Hypertension in 240 participants. Completed in 30 December 2024.
3 May 2021
Quick facts
| Lead sponsor | Johns Hopkins University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 240 |
| Start date | 14 July 2019 |
| Primary completion | 3 May 2021 |
| Estimated completion | 30 December 2024 |
| Sites | 4 locations across Ghana |
Drugs / interventions tested
- Enhanced Usual Care Group
- Usual Care Group — full drug profile →
Conditions studied
- Hypertension — all drugs for Hypertension →
- Diabetes — all drugs for Diabetes →
- Telemedicine — all drugs for Telemedicine →
Sponsor
Johns Hopkins University
Who can join
Adults 18 to 70, any sex, with Hypertension or Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A pilot cluster randomized control trial to test the feasibility of a multilevel, nurse-led, mobile health enhanced intervention in patients with uncontrolled hypertension in Ghana
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Addressing Hypertension Care in Africa (ADHINCRA): Study protocol for a cluster-randomized controlled pilot trial.
Commodore-Mensah Y, Sarfo FS, Turkson-Ocran RA, Foti K, et al · · 2023 · cited 4× · PMID 36592818 · DOI 10.1016/j.cct.2022.107077
Verify or expand the search:
- PubMed search for NCT04010344
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Enhanced Usual Care Group
Trials testing the same drug.
- NCT06541002 — A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors · NA · recruiting
- NCT06985199 — Culturally-adapted Mobile Health Intervention for Hypertension Care · NA · enrolling by invitation
- NCT03231592 — Im(Proving) the CSA Model · NA · unknown
- NCT01658670 — HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure · NA · completed
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Johns Hopkins University trials
Trials by the same sponsor.
- NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
- NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
- NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
- NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
- NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04010344 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
- Last refreshed: 17 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04010344.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing